eXoZymes, Inc. (EXOZ)
Healthcare
Biotechnology
4.70 $
+1.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns eXoZymes, Inc. (EXOZ)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.1% of the shares are freely tradable; institutional investors hold 0.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
0.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
65.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
68.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
0.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
9Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 0.37 | 31,516 | +21.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 0.26 | 22,190 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.26 | 21,891 | -7.1 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.11 | 9,426 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.08 | 6,797 | +8.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 0.26 | 21,799 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.12 | 10,311 | -0.4 | 04/30/2026 |
| iShares Micro-Cap ETF | 0.08 | 6,354 | +0.0 | 05/29/2026 |
| Fidelity Series Total Market Index | 0.04 | 2,944 | +0.0 | 04/30/2026 |
| Spartan Extended Market Index Pool F | 0.03 | 2,866 | +1.3 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.